Seven Bridges, founded in Cambridge, United States, is a leading biomedical data company dedicated to accelerating genomics research for cancer, drug development, and precision medicine. The company's core mission is to drive public and private healthcare research through advanced software and data analytics. Seven Bridges offers end-to-end bioinformatic solutions, including access to datasets, analytic workflows, algorithms, cloud-computing infrastructure, and scientific support, enabling researchers to transform raw experimental data into new treatments and diagnostics.

Notable affiliated individuals and investors include prominent figures in genomics and bioinformatics, although specific names are not provided. Key achievements of Seven Bridges include the development of comprehensive bioinformatic platforms that have significantly expedited the research process in genomics and clinical data analysis. The company's overall impact is seen in its contribution to faster and more efficient discovery of medical treatments and diagnostics, enhancing the capabilities of researchers and healthcare professionals globally.